Home/Pipeline/Acellular Pertussis Vaccine

Acellular Pertussis Vaccine

Prophylaxis against Pertussis

ApprovedMarketed

Key Facts

Indication
Prophylaxis against Pertussis
Phase
Approved
Status
Marketed
Company

About KM Biologics

A Japanese biopharmaceutical company developing and manufacturing vaccines and biologics for infectious disease prevention.

View full company profile

Therapeutic Areas